Tracking in at somewhere around $350 million, the Congressionally Directed Medical Research Program (CDMRP) is not a small program. It was created in 1992 to fund novel approaches to “biomedical research in response to the needs … of the American public, the...
Paradigm Shift for Long COVID Patients (and people with ME/CFS)? The dramatic announcement that Congress is going to appropriate over a billion dollars (a billion dollars!) to study the COVID-19 long haulers was just one sign that long COVID is being taken seriously....
Ivabradine appears to work quite well in POTS – but should we stop there? Ivabradine was approved for use in the European Union in 2005, but it’s pretty new to the scene in the U.S. It was FDA approved in only 2015. That means it doesn’t have much...
Emily Taylor of Solve ME/CFS Initiative reported that Congress has approved $1.15 billion (yes that’s a billion with a “B”) for the NIH to fund long-COVID research and clinical trials. $100 million will specifically be used for the rapid acceleration...
A riff on Dr. Peter Rowe’s presentation at the 2020 Dysautonomia International Conference (note that I expand on many of Rowe’s points; i.e. not all the words are his.) Lauren Stiles, the founder of Dysautonomia International, has long believed that the...
Keep the information flowing! Support Health Rising during our end of the year fundraising drive. Click here for more.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.